跳至主要内容
临床试验/NCT06280586
NCT06280586已完成不适用

Effectiveness of a Multimodal and Multidisciplinary Intervention (ESPAI-Fragility) in the Prevention of Sarcopenia, Frailty and Functional Decline in Pre-frail Elderly in the Community. Randomized Controlled Clinical Trial.

Consorci Sanitari del Maresme4 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2021年11月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
232
试验地点
4
主要终点
Muscle Mass

研究概览

简要总结

Frailty is a geriatric syndrome characterized by a decrease in the function of various organs and systems that leads to a greater risk of suffering from diseases or disabilities. Frailty is usually accompanied by weight loss, loss of strength, slowing of walking speed, fatigue and poor physical activity. Frail people have more difficulty in carrying out the usual activities of daily life and a greater risk of needing help to be able to do them.

The aim of this study is to evaluate the safety and effectiveness of an intervention based on the control of chronic diseases, a good use of medicines, diet, physical exercise and good social support, in the prevention . of frailty in old people who are at risk of frailty.

These criteria for participating in the study are why we invite you to participate. Your participation is voluntary. Your decision to participate or not in the study will not affect the medical care you may need. Before making a decision, read this information sheet carefully and ask the person who informs you the questions you want.

In the study there will be two groups, one will receive the study intervention and the other will not receive any special treatment (we call it the control group). The assignment of each individual to one group or the other will take place once you have decided to participate. This assignment will be made at random so that neither you nor your doctor can know "a priori" which group you will be in.

详细描述

General objective:

To assess the effectiveness and safety of a multimodal and multidisciplinary intervention in the prevention of sarcopenia, frailty and functional decline in pre-frail community elders aged 70 years or older.

Specific objectives:

  1. Evaluate the effect of the study intervention in the medium term (1 year) in terms of prevention or improvement of:

  2. Muscle strength, muscle mass and sarcopenia,

  3. The fragility

  4. Functional capacity (and/or dependence), balance and the risk of falls

  5. Nutritional status

  6. The quality of life

  7. The consumption of health resources in pre-frail community elders 70 years or older.

  8. To evaluate the safety of the mid-term study intervention (1 year) in pre-frail community elders aged 70 years or older.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women 70 years of age or older at the time of recruitment
  • That they meet pre-frail phenotype criteria according to L. Fried's criteria
  • That they give their written informed consent to participate in the study.

排除标准

  • Severe dementia (GDS>3)
  • Other neurodegenerative diseases (Parkinson's disease)
  • Neuromuscular diseases
  • Serious psychiatric illness that, at the doctor's discretion, prevents good compliance with the study intervention
  • Active cancer
  • Life expectancy of less than 6 months
  • Institutionalized patient
  • Unstable ischemic heart disease, uncontrolled arrhythmias, dissecting aortic aneurysm, severe aortic stenosis, uncontrolled arterial hypertension (>180/100mmHg), or severe heart failure.
  • Acute diseases or acute or poorly controlled chronic diseases
  • Bone fractures in the last 3 months.

研究组 & 干预措施

Control

No Intervention

Usual clinical practice

Intervention

Experimental
  • bimonthly personalized follow-up with the appropriate specialists (5 in a year) i

  • a program of group activities (6 sessions in a year) with a monitor with the aim of reinforcing adherence to the study intervention and adapting it to the circumstances and the physical, personal and social reality around each participant. The sessions will last approximately one hour and will cover:

  • General dietary and hydration recommendations and dietary recommendations for people at risk of malnutrition

  • Dietary and physical exercise recommendations in obese elderly

  • General physical exercise recommendations in the elderly and physical exercise recommendations in the elderly with sarcopenia

  • Physical exercise recommendations for the elderly at risk of falls.

  • Medication management and social resources for the elderly in Mataró.

干预措施: Multidisciplinary intervention (Other)

结局指标

主要结局

Muscle Mass

时间窗: baseline, 6 months and 12 months

Bioimpedance

Sarcopenia

时间窗: baseline, 6 months and 12 months

EWGSOP2 description

Frailty

时间窗: baseline, 6 months and 12 months

L Fried Criteria

Muscle strength and/or Muscle function

时间窗: baseline, 6 months and 12 months

Isokinetic

次要结局

  • Functional Capacity 2(baseline, 6 months and 12 months)
  • Functional Capacity 1(baseline, 6 months and 12 months)
  • Functional Capacity 3(baseline, 6 months and 12 months)
  • Functional Capacity 4(baseline, 6 months and 12 months)
  • Functional Capacity 5(baseline, 6 months and 12 months)
  • Functional Capacity 6(baseline, 6 months and 12 months)

研究者

发起方
Consorci Sanitari del Maresme
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mateu Serra Prat

MD PhD

Consorci Sanitari del Maresme

研究点 (4)

Loading locations...

相似试验